Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Flecainide

🥰Excellent
Catalog No. T21391Cas No. 54143-55-4
Alias Apocard

Flecainide is an orally administered antiarrhythmic agent acting as a sodium channel blocker and IKr inhibitor, indicated for the treatment of paroxysmal supraventricular tachycardia (PSVT).

Flecainide

Flecainide

🥰Excellent
Purity: 99.896%
Catalog No. T21391Alias ApocardCas No. 54143-55-4
Flecainide is an orally administered antiarrhythmic agent acting as a sodium channel blocker and IKr inhibitor, indicated for the treatment of paroxysmal supraventricular tachycardia (PSVT).
Pack SizePriceAvailabilityQuantity
5 mg$40In Stock
10 mg$64In Stock
25 mg$119In Stock
50 mg$197In Stock
100 mg$297In Stock
200 mg$373In Stock
1 mL x 10 mM (in DMSO)$44In Stock
Add to Cart
Add to Quotation
Bulk & Custom
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
View More

Batch Information

Select Batch
Purity:99.896%
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Flecainide is an orally administered antiarrhythmic agent acting as a sodium channel blocker and IKr inhibitor, indicated for the treatment of paroxysmal supraventricular tachycardia (PSVT).
Targets&IC50
CHO cells:27.1 μM
In vitro
Methods: Flecainide (6 μM) was used to treat ventricular myocytes from Casq2-/- mice to observe spontaneous sarcoplasmic reticulum calcium release events and triggered activity.
Result: Flecainide significantly suppressed the spontaneous sarcoplasmic reticulum calcium release events and triggered activity induced by adrenergic stimulation.[1]
In vivo
Methods: Flecainide (20 mg/kg) was administered intraperitoneally to Casq2-/- mice to observe its inhibitory effect on arrhythmia. 
Result: Flecainide completely suppressed adrenaline-induced arrhythmia, including premature ventricular contractions and bidirectional ventricular tachycardia.[1]
SynonymsApocard
Chemical Properties
Molecular Weight414.34
FormulaC17H20F6N2O3
Cas No.54143-55-4
SmilesFC(F)(F)COc1ccc(OCC(F)(F)F)c(c1)C(=O)NCC1CCCCN1
Relative Density.1.31g/cm3
ColorWhite
AppearanceSolid
Storage & Solubility Information
Storagekeep away from direct sunlight,store under nitrogen | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
H2O: Insoluble
DMSO: 80 mg/mL (193.08 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.4135 mL12.0674 mL24.1348 mL120.6738 mL
5 mM0.4827 mL2.4135 mL4.8270 mL24.1348 mL
10 mM0.2413 mL1.2067 mL2.4135 mL12.0674 mL
20 mM0.1207 mL0.6034 mL1.2067 mL6.0337 mL
50 mM0.0483 mL0.2413 mL0.4827 mL2.4135 mL
100 mM0.0241 mL0.1207 mL0.2413 mL1.2067 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
All types of co-solvents required for the protocol, such asDMSO, PEG300/ PEG400, Tween 80, SBE-β-CD, corn oil are available for purchase on the TargetMol website with a simple click.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Sci Citations

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Flecainide | purchase Flecainide | Flecainide cost | order Flecainide | Flecainide chemical structure | Flecainide in vivo | Flecainide in vitro | Flecainide formula | Flecainide molecular weight